285 related articles for article (PubMed ID: 15987428)
1. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study.
Lord SJ; Mack WJ; Van Den Berg D; Pike MC; Ingles SA; Haiman CA; Wang W; Parisky YR; Hodis HN; Ursin G
Breast Cancer Res; 2005; 7(3):R336-44. PubMed ID: 15987428
[TBL] [Abstract][Full Text] [Related]
2. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in genes involved in the estrogen pathway and mammographic density.
Dumas I; Diorio C
BMC Cancer; 2010 Nov; 10():636. PubMed ID: 21092186
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in steroid hormone pathway genes and mammographic density.
Haiman CA; Hankinson SE; De Vivo I; Guillemette C; Ishibe N; Hunter DJ; Byrne C
Breast Cancer Res Treat; 2003 Jan; 77(1):27-36. PubMed ID: 12602902
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.
Diergaarde B; Potter JD; Jupe ER; Manjeshwar S; Shimasaki CD; Pugh TW; Defreese DC; Gramling BA; Evans I; White E
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1751-9. PubMed ID: 18628428
[TBL] [Abstract][Full Text] [Related]
7. Postmenopausal hormone therapy and change in mammographic density.
Greendale GA; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Ursin G
J Natl Cancer Inst; 2003 Jan; 95(1):30-7. PubMed ID: 12509398
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
[TBL] [Abstract][Full Text] [Related]
9. Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
Byrne C; Ursin G; Martin CF; Peck JD; Cole EB; Zeng D; Kim E; Yaffe MD; Boyd NF; Heiss G; McTiernan A; Chlebowski RT; Lane DS; Manson JE; Wactawski-Wende J; Pisano ED
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376149
[TBL] [Abstract][Full Text] [Related]
10. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators.
Greendale GA; Reboussin BA; Sie A; Singh HR; Olson LK; Gatewood O; Bassett LW; Wasilauskas C; Bush T; Barrett-Connor E
Ann Intern Med; 1999 Feb; 130(4 Pt 1):262-9. PubMed ID: 10068383
[TBL] [Abstract][Full Text] [Related]
11. Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.
Wang Q; Li H; Tao P; Wang YP; Yuan P; Yang CX; Li JY; Yang F; Lee H; Huang Y
DNA Cell Biol; 2011 Aug; 30(8):585-95. PubMed ID: 21438753
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
[TBL] [Abstract][Full Text] [Related]
13. The Val432Leu polymorphism of the CYP1B1 gene is associated with differences in estrogen metabolism and bone density.
Napoli N; Rini GB; Serber D; Giri T; Yarramaneni J; Bucchieri S; Camarda L; Di Fede G; Camarda MR; Jain S; Mumm S; Armamento-Villareal R
Bone; 2009 Mar; 44(3):442-8. PubMed ID: 18977467
[TBL] [Abstract][Full Text] [Related]
14. Changes in 2-hydroxyestrone and 16alpha-hydroxyestrone metabolism with flaxseed consumption: modification by COMT and CYP1B1 genotype.
McCann SE; Wactawski-Wende J; Kufel K; Olson J; Ovando B; Kadlubar SN; Davis W; Carter L; Muti P; Shields PG; Freudenheim JL
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):256-62. PubMed ID: 17301257
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
Arch Toxicol; 2002 Nov; 76(11):643-9. PubMed ID: 12415427
[TBL] [Abstract][Full Text] [Related]
16. Adipose tissue PCB levels and CYP1B1 and COMT genotypes in relation to breast cancer risk in postmenopausal Danish women.
Bräuner EV; Loft S; Wellejus A; Autrup H; Tjønneland A; Raaschou-Nielsen O
Int J Environ Health Res; 2014; 24(3):256-68. PubMed ID: 23869875
[TBL] [Abstract][Full Text] [Related]
17. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Ursin G; Palla SL; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Greendale GA
J Clin Oncol; 2004 Jul; 22(14):2842-8. PubMed ID: 15254051
[TBL] [Abstract][Full Text] [Related]
18. An investigation of mammographic density and gene variants in healthy women.
Maskarinec G; Lurie G; Williams AE; Le Marchand L
Int J Cancer; 2004 Nov; 112(4):683-8. PubMed ID: 15382051
[TBL] [Abstract][Full Text] [Related]
19. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women.
Tworoger SS; Chubak J; Aiello EJ; Ulrich CM; Atkinson C; Potter JD; Yasui Y; Stapleton PL; Lampe JW; Farin FM; Stanczyk FZ; McTiernan A
Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):94-101. PubMed ID: 14744739
[TBL] [Abstract][Full Text] [Related]
20. Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women.
Warren R; Skinner J; Sala E; Denton E; Dowsett M; Folkerd E; Healey CS; Dunning A; Doody D; Ponder B; Luben RN; Day NE; Easton D
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1502-8. PubMed ID: 16896040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
